Back to Search
Start Over
Cardiovascular Safety During and After Use of Phentermine and Topiramate.
- Source :
- The Journal of Clinical Endocrinology & Metabolism; February 2019, Vol. 104 Issue: 2 p513-522, 10p
- Publication Year :
- 2019
-
Abstract
- Increases in heart rate were seen during the clinical program for fixed-dose combination phentermine (PHEN) and topiramate (TPM), an oral medication indicated for weight management; however, the effect on cardiovascular (CV) outcomes is uncertain.
Details
- Language :
- English
- ISSN :
- 0021972X and 19457197
- Volume :
- 104
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- The Journal of Clinical Endocrinology & Metabolism
- Publication Type :
- Periodical
- Accession number :
- ejs51162533
- Full Text :
- https://doi.org/10.1210/jc.2018-01010